Investigating Stem Cell Misspecification and Tumor Heterogeneity in Cutaneous Basal Cell Carcinoma Open Access
Patel, Kush (Spring 2025)
Abstract
The epidermal barrier consists of adherent, polarized epithelial cell layers that require continuous
replenishment by basal stem cells, whose proliferative nature is believed to contribute to skin
tumorigenesis. Our previous work in a cisplatin-treated mouse model demonstrated that IL-1β
secretion following NLRP3 inflammasome activation in dermal fibroblasts induces epidermal
hyperplasia and disrupts stem cell differentiation, resembling tumorigenic behaviors. In this study,
we investigated whether stem cell misspecification and inflammasome activation contribute to
cutaneous basal cell carcinoma (cBCC) tumorigenesis, the most common human cancer. Using an
established cBCC mouse model in which the Sonic Hedgehog pathway is constitutively activated,
we analyzed stem cell misspecification and inflammasome activation through
immunofluorescence and confocal microscopy. We observed no inflammasome activation in
cBCC tumors, suggesting this signaling pathway does not contribute to tumorigenesis. However,
we identified two distinct tumor subtypes: macrotumors, composed primarily of K14+ basal stem
cells, and microtumors, which contained K10/K14 dual-positive cells, reminiscent of stem cell
misspecification previously observed in our cisplatin-treated model. To further distinguish these
tumor types, we analyzed proliferation markers and found that macrotumors exhibited widespread
BrdU expression, indicating high levels of proliferation, whereas microtumors displayed
proliferation in small cell subpopulations, suggesting proliferative heterogeneity. Given these
differences in tumor architecture and proliferation, our future work will investigate the
mechanisms driving differential proliferation across tumor cell populations. Using a transgenic
cBCC mouse model, we will culture distinct tumor cell populations to assess the plasticity and
lineage potential of K14+ and K10/K14 dual-positive cells and perform spatial transcriptomics to
uncover molecular mechanisms underlying these distinctions. Identifying the molecular drivers of
tumor heterogeneity may reveal novel therapeutic targets for regulating tumor growth and
differentiation in cBCC.
Table of Contents
Chapter I: Introductions .......................................................................................................1
Chapter II: Materials and Methods ....................................................................................15
Chapter III: Results ............................................................................................................21
Chapter IV: Discussion ......................................................................................................33
References ..........................................................................................................................42
About this Honors Thesis
| School | |
|---|---|
| Department | |
| Degree | |
| Submission | |
| Language |
|
| Keyword | |
| Committee Chair / Thesis Advisor | |
| Committee Members |
Primary PDF
| Thumbnail | Title | Date Uploaded | Actions |
|---|---|---|---|
|
|
Investigating Stem Cell Misspecification and Tumor Heterogeneity in Cutaneous Basal Cell Carcinoma () | 2025-04-08 13:47:09 -0400 |
|
Supplemental Files
| Thumbnail | Title | Date Uploaded | Actions |
|---|